Clinical Trial Update: Anticoagulant After Implantation of Biological Aortic Valve Comparing With Aspirin [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing an anticoagulant with aspirin after biological aortic valve implantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bleeding
• Thromboembolism

Drugs mentioned

• Anticoagulant (unspecified) (anticoagulant)
• Aspirin (Aspirin)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Thromboembolism, Bleeding | Phase 4 | Status: COMPLETED